Media Advisory – CanniMed Therapeutics Inc. and Up Cannabis Inc. CEOs to Speak at the AltaCorp Capital 6th Annual Institutional Investor Conference

SASKATOON, Saskatchewan & OAKVILLE, Ontario--()--CanniMed Therapeutics Inc. (TSX: CMED) (“CanniMed”) and Up Cannabis Inc. (wholly-owned licensed producer of Newstrike Resources Ltd. (TSX-V: HIP) (“Up Cannabis”) are pleased to be participating in the AltaCorp Capital Institutional Investor Conference on Wednesday, January 10th at the Shangri-La Hotel in Toronto.

Speakers: Brent Zettl, President and CEO, CanniMed Therapeutics Inc.
Jay Wilgar, President and CEO, Newstrike and Up Cannabis Inc.

Date and Time: Wednesday, January 10, 2018; 11:30-11:55 am

Location: Shangri-La Hotel Toronto

Media webcast: www.meetview.com/AltaCorp-ATB2018

Note that the meeting attendance is limited to investors and analysts.

Slides will be available on CanniMed Therapeutics Inc. website prior to the presentation at:

https://www.cannimedtherapeutics.com/investors/events-and-presentations/presentations/default.aspx

Contacts

Media
CanniMed Therapeutics Inc.
Dara Willis, 416-836-9272
dhw@cannimed.com
or
Up Cannabis
PM Rendon, 365-773-5432
pm@up.ca

Release Summary

CanniMed and Newstrike CEOs to Present at AltaCorp Capital Annual Institutional Investor Conference Wednesday

Contacts

Media
CanniMed Therapeutics Inc.
Dara Willis, 416-836-9272
dhw@cannimed.com
or
Up Cannabis
PM Rendon, 365-773-5432
pm@up.ca